Novel SCN9A Mutations in a Compound Heterozygous Girl with Congenital Insensitivity to Pain

B. Stunnenberg, M. Ponson-Wever*, E. Verberne, I. Peters, M. Gerrits, C. Haaxma, M. van Haelst

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Web of Science)


Congenital Insensitivity to Pain (CIP) is a rare disorder that is characterized by the inability to perceive pain. It is caused by bi-allelic inactivating mutations in the SCN9A gene, which encodes the pore-forming alpha-subunit of the nerve voltage-gated sodium channel (Na(v)1.7). Patients with CIP are unable to feel pain from noxious stimuli, including heat, but all other peripheral somatosensory modalities function normally. Often anosmia is present as an additional feature. We reported a patient with CIP caused by compound heterozygous SCN9A mutations: a novel in-frame deletion of exon 7 and a novel frameshift mutation. The identification of these mutations expands the spectrum of mutations associated with CIP.
Original languageEnglish
Pages (from-to)189-192
Number of pages4
JournalJournal of Pediatric Neurology
Issue number03
Publication statusPublished - 1 Jun 2021


  • congenital insensitivity to pain
  • SCN9A
  • anosmia

Cite this